Literature DB >> 15127406

The in vivo calcification capacity of a copolymer, based on methacryloyloxyethyl phosphate, does not favor osteoconduction.

I C Stancu1, R Filmon, F Grizon, C Zaharia, C Cincu, M F Baslé, D Chappard.   

Abstract

Polymers can be interesting alternatives to bone grafts; they must present suitable mechanical and osteoconductive properties. Biomimetic properties may be a key factor for the recognition by bone cells. Methacryloyloxyethyl phosphate (MOEP) was found to enhance hydroxyapatite deposition. The copolymer containing MOEP and 1-vinyl-2-pyrrolidinone (50-50%) binds large amounts of calcium. Particles of the copolymer were used to fill large cranial bone defects in the rat. After a 12-week healing period, the animals were euthanized and the skulls examined by X-ray, histology, and electron microscopy (EM). The high phosphate content of the polymer conferred a marked calcium-binding capacity, and the particles were heavily calcified. They were embedded in a light fibrous stroma containing numerous capillaries and multinucleated giant cells. The osteoconductive properties were poor: only few trabeculae developed centripetally from the margins of the defects. There was no bone bonding and no osteoblast on the surface of the calcified material. Backscattered EM revealed that the degree of calcification was homogeneous in all particles. Calcium-phosphorus calcospherites were never observed. The material appeared to trap calcium but to impair nucleation because only small hydroxyapatite tablets were occasionally observed. Polyphosphated materials do not represent a suitable source of potentially usable bone substitutes. Copyright 2004 Wiley Periodicals, Inc. J Biomed Mater Res 69A: 584-589, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15127406     DOI: 10.1002/jbm.a.30036

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  1 in total

1.  Phosphorous-containing polymers for regenerative medicine.

Authors:  Brendan M Watson; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomed Mater       Date:  2014-02-24       Impact factor: 3.715

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.